About this trial
Sprint interval training improves endurance performance and induces metabolic adaptations in muscle. Most research demonstrating these responses has been conducted in males, with limited studies evaluating changes to endurance performance and skeletal muscle oxidative capacity in females. Moreover, it is currently unknown if training in specific phases of the menstrual cycle influences adaptations to training. Thus, the purpose of the present study is to compare adaptations to 2 weeks of sprint interval training performed in the follicular vs. luteal phase of the menstrual cycle in healthy, eumenorrheic women.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participating in 150 min of moderate-vigorous physical activity/week
VO2peak of 'good' or above based on American College of Sport Medicine (ACSM) normative values(greater than 35.0ml/kg/min)
Body mass index (BMI) between 18-27 kg/m2
Performing 2-4 structured exercise sessions/week.
Disqualifiers
Hormonal contraceptive use within the last 3 months
Polycystic ovarian syndrome (PCOS) or endometriosis
Failure to meet MC verification criteria.
Diagnosed with cardiovascular or metabolic disease, hyper- or hypogonadism, and/or PCOS
Trial design
Parallel
Treatments tested in this trial
Sprint Interval Training
Other intervention6 sessions of sprint interval training over 2 weeks. Each session involves 4-6 x 30 second Wingate sprints with 4 minutes of recovery in between on a stationary bike
Treatment groups
Trial outcomes
Primary outcomes
Endurance performance
Time to completion and average power output during a 250kJ time trial
Secondary outcomes
Skeletal muscle mitochondrial content
Measured via Western blotting
Skeletal muscle mitochondrial enzyme activity
Measured via enzyme activity assays
Skeletal muscle capillarization
Measured via immunofluorescence
Skeletal muscle lipid content
Measured via immunofluorescence
Sponsors and contacts
Click on the lead sponsor to view all of their trials.